stock manipulation

Ostin Technology faces class action lawsuit alleging securities fraud scheme involving fraudulent offerings and stock price manipulation that netted $110 million before collapsing 94%.

Richtech Robotics faces securities lawsuit after overstating Microsoft partnership, causing 30% stock surge followed by 20% decline when Microsoft clarified limited engagement.

Class action lawsuits filed against PomDoctor and Vistagen Therapeutics alleging securities violations. Vistagen's stock fell 80% after failed clinical trial results.

Schall Law Firm files securities fraud class action against Picard Medical for allegedly misleading investors through false statements and an alleged "pump and dump" scheme during September-October 2025.

Law firm seeks lead plaintiffs for MCTA class action lawsuit over alleged undisclosed stock promotion scheme and social media fraud. Deadline: February 17, 2026.

Pomdoctor investors must act by April 13, 2026, to join securities fraud class action alleging false statements and manipulated trading volumes that caused stock decline.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements and share price manipulation during fall 2025. Investors who purchased shares during this period may be eligible for damages.

Class action filed against Charming Medical for alleged stock price manipulation through coordinated social media promotion. Trading suspended pending SEC investigation.